Substituted pyrazines as DGAT-1 inhibitors
US8188092B2 · kind B2 · utility
6Cited by
9References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2010 |
| Grant date | May 29, 2012 |
| Priority date | — |
| Expiry date | Jun 18, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro-drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, obesity
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.